[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:parkinson-disease:lrrk2-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Parkinson Disease","LRRK2 Gene",4,[8,16,22,28],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06680830","A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease",[12],"Phase 2","RECRUITING","2026-08-26T02:16:08.402952Z","2026-05-05T02:43:27.104900Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07642908","Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation",[],"2026-08-26T02:17:16.980188Z","2026-06-14T18:39:22.260693Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT04477785","PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort",[],"2026-08-26T02:15:43.339060Z","2026-05-13T02:55:06.251770Z",{"nct_id":29,"title":30,"phases":31,"status":32,"updated_at":33,"content_modified":34},"NCT06602193","Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:39:57.435220Z","2026-05-05T02:43:29.326271Z"]